Alan M. F. Stapleton

3.4k total citations · 1 hit paper
36 papers, 2.6k citations indexed

About

Alan M. F. Stapleton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Alan M. F. Stapleton has authored 36 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Alan M. F. Stapleton's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Kidney Stones and Urolithiasis Treatments (7 papers). Alan M. F. Stapleton is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Kidney Stones and Urolithiasis Treatments (7 papers). Alan M. F. Stapleton collaborates with scholars based in Australia, United States and New Zealand. Alan M. F. Stapleton's co-authors include Thomas M. Wheeler, Michael W. Kattan, James A. Eastham, Peter T. Scardino, Farhang Rabbani, Carole Pinnock, Rosemary L. Ryall, Villis R. Marshall, Timothy C. Thompson and Guang Yang and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and Biochemical Journal.

In The Last Decade

Alan M. F. Stapleton

36 papers receiving 2.5k citations

Hit Papers

A Preoperative Nomogram for Disease Recurrence Following ... 1998 2026 2007 2016 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
    1998 991 citations Michael W. Kattan, James A. Eastham et al. JNCI Journal of the National Cancer Institute profile →

Peers

Alan M. F. Stapleton
Peter Hammerer Germany
Edith Canby‐Hagino United States
Ubirajara Ferreira Brazil
Mark F. Wildhagen Netherlands
Zhaoyong Feng United States
Bo Johan Norlén Sweden
A. Rodrı́guez-Antolı́n Spain
Michael Häggman Sweden
A. Akdaş Türkiye
F. Zattoni Italy
Peter Hammerer Germany
Alan M. F. Stapleton
Citations per year, relative to Alan M. F. Stapleton Alan M. F. Stapleton (= 1×) peers Peter Hammerer

Countries citing papers authored by Alan M. F. Stapleton

Since Specialization
Citations

This map shows the geographic impact of Alan M. F. Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. F. Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. F. Stapleton more than expected).

Fields of papers citing papers by Alan M. F. Stapleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. F. Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. F. Stapleton. The network helps show where Alan M. F. Stapleton may publish in the future.

Co-authorship network of co-authors of Alan M. F. Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Alan M. F. Stapleton. A scholar is included among the top collaborators of Alan M. F. Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan M. F. Stapleton. Alan M. F. Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kench, James G., David Clouston, Warick Delprado, et al.. (2011). Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens. Pathology. 43(5). 410–419. 6 indexed citations
2.
Beckmann, Kerri, et al.. (2009). Clinical and socio‐demographic profile of an Australian multi‐institutional prostate cancer cohort. Asia-Pacific Journal of Clinical Oncology. 5(4). 247–256. 12 indexed citations
3.
Stapleton, Alan M. F. & Carole Pinnock. (2005). Nomograms for prostate cancer—is their use evidence-based?. Nature Clinical Practice Urology. 2(10). 462–463. 3 indexed citations
4.
5.
Hall, Rosemary E., Debbie Horsfall, Carmela Ricciardelli, et al.. (2003). Apolipoprotein‐D: A novel cellular marker for HGPIN and prostate cancer. The Prostate. 58(2). 103–108. 31 indexed citations
6.
7.
Moghaddami, Mahin, et al.. (2001). CD40 is not detected on human prostate cancer cells by immunohistologic techniques. Urology. 57(3). 573–578. 5 indexed citations
8.
Grover, Phulwinder K., Alan M. F. Stapleton, Katsuhito Miyazawa, & Rosemary L. Ryall. (2001). Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR. Biochemical Journal. 356(1). 111–111. 9 indexed citations
9.
Stapleton, Alan M. F., et al.. (2001). Attitudes to evidence‐based practice in urology: Results of a survey. ANZ Journal of Surgery. 71(5). 297–300. 15 indexed citations
10.
Grover, Phulwinder K., et al.. (2000). The prothrombin gene is expressed in the rat kidney. European Journal of Biochemistry. 267(1). 61–67. 19 indexed citations
11.
Rabbani, Farhang, Alan M. F. Stapleton, Michael W. Kattan, Thomas M. Wheeler, & Peter T. Scardino. (2000). FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY. The Journal of Urology. 164(6). 1929–1934. 361 indexed citations
12.
Pinnock, Carole, Alan M. F. Stapleton, & Villis R. Marshall. (1999). Erectile dysfunction in the community: a prevalence study. The Medical Journal of Australia. 171(7). 353–357. 119 indexed citations
13.
Kattan, Michael W., et al.. (1999). A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer. The Journal of Urology. 161(1). 354–355. 37 indexed citations
14.
Kattan, Michael W., et al.. (1998). A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer. JNCI Journal of the National Cancer Institute. 90(10). 766–771. 991 indexed citations breakdown →
15.
Stapleton, Alan M. F., et al.. (1996). Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix. Kidney International. 49(3). 880–888. 42 indexed citations
16.
Robinson, R. G., et al.. (1995). STRUVITE RENAL CALCULI CAUSED BY CORYNEBACTERIUM GROUP D2. Australian and New Zealand Journal of Surgery. 65(4). 294–295. 1 indexed citations
17.
Stapleton, Alan M. F., et al.. (1995). Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the Fl activation peptide of human prothrombin. British Journal of Urology. 75(6). 712–719. 60 indexed citations
18.
Stapleton, Alan M. F., A. E. Seymour, James S. Brennan, et al.. (1993). Immunohistochemical distribution and quantification of crystal matrix protein. Kidney International. 44(4). 817–824. 41 indexed citations
19.
Stapleton, Alan M. F., Richard J. Simpson, & Rosemary L. Ryall. (1993). Crystal Matrix Protein Is Related to Human Prothrombin. Biochemical and Biophysical Research Communications. 195(3). 1199–1203. 22 indexed citations
20.
Stapleton, Alan M. F., et al.. (1990). Microwave Warming of 1.5% Glycine Solution. British Journal of Urology. 65(3). 286–287. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hammerer Breakdown of academic impact, for papers by Edith Canby‐Hagino Breakdown of academic impact, for papers by Ubirajara Ferreira Breakdown of academic impact, for papers by Mark F. Wildhagen Breakdown of academic impact, for papers by Zhaoyong Feng Breakdown of academic impact, for papers by Bo Johan Norlén Breakdown of academic impact, for papers by A. Rodrı́guez-Antolı́n Breakdown of academic impact, for papers by Michael Häggman Breakdown of academic impact, for papers by A. Akdaş Breakdown of academic impact, for papers by F. Zattoni
Rankless by CCL
2026